- Book
- April 2018
- 176 Pages
- Book
- July 2024
- 256 Pages
- Book
- May 2022
- 512 Pages
- Book
- April 2022
- 352 Pages
- Book
- March 2022
- 896 Pages
- Book
- August 2021
- 304 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2020
- 3632 Pages
- Book
- March 2019
- 348 Pages
- Book
- April 2018
- 384 Pages
- Book
- March 2018
- 440 Pages
- Book
- January 2014
- 216 Pages
- Book
- May 2013
- 384 Pages
- Book
- April 2013
- 580 Pages
- Book
- September 2012
- 688 Pages
- Book
- July 2011
- 396 Pages
- Book
- July 2011
- 800 Pages
- Book
- July 2010
- 328 Pages
- Book
- July 2010
- 534 Pages
- Book
- January 2008
- 453 Pages

The Transcriptomics market is a segment of the biotechnology industry that focuses on the study of gene expression. It involves the analysis of the transcriptome, which is the set of all RNA molecules in a cell. This includes mRNA, tRNA, and rRNA. Transcriptomics is used to study gene expression, regulation, and function. It is used to identify and characterize genes, as well as to understand the role of genes in disease and development. Transcriptomics can also be used to identify biomarkers for diagnosis and prognosis, and to develop new therapeutic targets.
Some companies in the Transcriptomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more